Seaweed Alzheimer’s Drug Approved for U.S. Clinical Trials — First New Drug in 17 years
While pharmaceutical companies have invested decades of research and billions of dollars in the quest to cure to Alzheimer’s, more than 100 experimental therapies have either been abandoned in development or failed in clinical trials. A Shanghai drugmaker’s experimental ‘seaweed drug’ is the next glimmer of hope.
